“Adjusted mean SE ) change in HR with empagliflozin compared to placebo was -0.8 (0.3); p < 0.05.”
“…,empagliflozin significantly reduced HbA1c (mean [SE] …]; p < 0.001), SBP (mean [ SE ]: -3.6 [0.5] mmHg; p < 0.001), DBP (mean [SE]: -1.3 [0.3] mmHg; p < 0.001), … [0.4] mmHg; p < 0.001) and MAP (mean [SE]: -2.1 [0.3] mmHg; p < 0.001).”